Anaphylaxis is a serious allergic reaction that is rapid in onset and includes signs and symptoms that involve the skin, gastrointestinal track, respiratory system, and cardiovascular system. 1 The most severe form of anaphylaxis is anaphylactic shock, which is characterized by hypotension and can cause death. 1 Anaphylaxis can be caused by allergies to foods, insect venoms, medications, and other agents. 1 The incidence of food-induced anaphylaxis has increased at an alarming rate, especially in children in developed countries, during the past several decades and continues to increase. [2] [3] [4] Understanding the molecular regulation of anaphylactic shock is an important step in developing effective prevention and treatment.
Mast cells are mononuclear protease granule-containing cells that display FcεRI, the high-affinity receptor for IgE, on the cell surface. FcεRI is a heterotetramer composed of 1 IgE-binding a subunit, 1 membrane-tetraspanning b subunit, and a dimer of disulfide-linked g subunits. Mast cells can be activated by antigen cross-linking of specific IgE associated with FcεRI. Mast cell activation by IgE/FcεRI cross-linking induces degranulation, with release of inflammatory mediators, including histamine, and secretion of both preformed and newly synthesized cytokines. Although cytokines induce allergic inflammation, histamine has a major role in causing IgE-mediated anaphylactic shock. [5] [6] [7] Mice genetically deficient in mast cells or depleted of mast cells by treatment with anti-stem cell factor antibody are unable to develop IgE-mediated anaphylactic shock. 6, 7 Amelioration of peanut allergy by treatment with the anti-IgE mAb omalizumab supports the importance of IgE/mast cells in mediating human anaphylactic shock. 8 Histamine is produced by decarboxylation of the amino acid histidine, a reaction catalyzed by the enzyme histidine decarboxylase (HDC). 9, 10 The Hdc gene encodes HDC, the rate-limiting enzyme that is essential for mouse and human histamine synthesis. 9, 11, 12 Mice deficient in the Hdc gene do not synthesize histamine and have reduced or absent IgE-mediated anaphylactic responses. [13] [14] [15] [16] There is only limited knowledge of how Hdc gene expression is regulated. The transcription factor SP1 binds to a GC box found in both the human and mouse Hdc gene promoters. 17, 18 Several promoter elements that negatively regulate Hdc gene transcription have been reported. For example, YY1 and KLF4 negatively regulate the Hdc gene by suppressing SP1 in a gastric cancer cell line. 19, 20 GATA2 is a member of the GATA family of transcription factors. GATA2 has been shown to be critical for survival and proliferation of hematopoietic stem cells, 21, 22 granulocytemonocyte progenitor differentiation, 23 and basophil and mast cell differentiation. 24, 25 Recently, we demonstrated that GATA2 plays a critical role in regulating Hdc gene expression in mast cells. 26 However, the in vivo role of GATA2 in regulating IgE/ mast cell-mediated anaphylaxis is not clear.
Microphthalmia-associated transcription factor (MITF) plays a critical role in mast cell differentiation. A MITF null mutation results in loss of c-Kit expression and severely impairs mast cell differentiation in C57BL/6 mice, 27, 28 although this mutation does not affect mast cell differentiation in WB mice because of overproduction of the c-Kit ligand stem cell factor in this strain. 29 We reported that MITF is sufficient to induce the differentiation of common basophil/mast cell progenitor pre-basophil and mast cell progenitors (pre-BMPs) into mast cells and is required to maintain mast cell identity. 30 However, it is unknown whether MITF regulates the Hdc gene in either mouse or human mast cells. Furthermore, the mechanisms by which GATA2 and MITF regulate the Hdc gene have not been investigated.
In this study we investigated the in vivo roles of GATA2 and MITF in IgE/mast cell-mediated anaphylaxis. We determined that GATA2 is required for connective tissue mast cell (CTMC) differentiation and for maintaining the expression of genes required for anaphylaxis in vivo. MITF, but not other GATA2-dependent transcription factors, is critical for regulating IgE/ mast cell-mediated anaphylaxis. We observed that MITF binds the -8.8 Hdc enhancer and is important for the activities of its enhancer. Our results indicate that the transcription factors GATA2 and MITF control IgE/mast cell-mediated anaphylaxis mainly by regulating Hdc gene expression in mast cells.
METHODS Mice
Mouse information is described in detail in the Methods section in this article's Online Repository at www.jacionline.org. All animal experiments were conducted according to protocols approved by the National Jewish Health Institutional Animal Care and Use Committee (Denver, Colo).
Fluorescence-activated cell sorting analysis
Cells prepared from various tissues were stained with fluorochromelabeled antibodies. Stained cells were acquired by using CyAN (DakoCytomation, Glostrup, Denmark) and analyzed with FlowJo software (TreeStar, Ashland, Ore). Cell sorting was carried out with a MoFlo cytometer (DakoCytomation). A more detailed description of cell-surface markers used is included in the Methods section in this article's Online Repository.
Quantitative RT-PCR
Quantitative RT-PCR (qPCR) measurements were performed as described in detail in the Methods section in this article's Online Repository. Primer sequences are listed in Table E1 in this article's Online Repository at www. jacionline.org. qPCR analysis was carried out as described in detail in the Methods section in this article's Online Repository.
Passive cutaneous anaphylaxis
Mice were sensitized with IgE anti-2, 4, 6-trinitrophenyl (TNP) antibody and challenged with TNP-BSA (300 mg/300 mL of PBS) and 0.5% Evans blue dye by means of intravenous injection. Thirty minutes after challenge, ears were collected and incubated in dimethylformamide for 48 hours, after which absorbance of the dimethylformamide at 620 nm (OD620 nm) was measured. See the Methods section in this article's Online Repository for further details.
Passive systemic anaphylaxis
Mice were sensitized with 10 mg of IgE anti-TNP antibody and challenged with 10 mg of TNP-BSA. Rectal temperatures of the challenged mice were measured before challenge (0 minutes) and at 5, 10, 15, 20, 25, 30, 40, 60, 80 , 100, and 120 minutes after challenge. See the Methods section in this article's Online Repository for further details.
Chromatin immunoprecipitation sequencing
DNA fragments associated with monomethylation of lysine residue 4 on histone 3 (H3K4me1) or acetylation of lysine residue 27 on histone 3 (H3K27ac) were immunoprecipitated by using respective specific antibodies obtained from Abcam (Cambridge, Mass). The immunoprecipitated DNA fragments were repaired, ligated to adapters, and size selected to libraries, which were sequenced as reported previously. 31 Reads were aligned to the mouse reference genome, and peaks were called, comparing an immunoprecipitated sample with its corresponding input sample. Chromatin immunoprecipitation sequencing (ChIP-seq) data were visualized with the Integrative Genomics Viewer. 32, 33 Data can be accessed at the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo, GSE97253). See the Methods section in this article's Online Repository for further details.
Statistical analysis
All the error bars in this report represent SEMs. For ELISA, qPCR, and luciferase analyses, means 6 SEMs were derived from data pooled from 2 or 3 independent experiments. Results from each independent experiment are detailed in Figs E1 to E13 in this article's Online Repository at www. jacionline.org. Differences between paired samples were analyzed by using the Student t test. Changes at various time points before and after challenge in passive systemic anaphylaxis (PSA) analyses were analyzed by using 2-way repeated-measures ANOVA.
Other methods, including cell culture, histology, ELISA measurements, plasmid construction, adoptive transfer of bone marrow-derived mast cells (BMMCs), luciferase reporter assay, retroviral infection, ChIP, and cholera toxin treatment of BMMCs, are included in the Methods section in this article's Online Repository.
RESULTS
GATA2 is critical for CTMC differentiation and IgE/ mast cell-mediated anaphylaxis GATA2 exerts its functions at multiple developmental stages of hematopoiesis. Previously, we reported that Gata2 mRNA expression is upregulated in common basophil and mast cell progenitors (pre-BMPs). 26 GATA2 is required for differentiation of pre-BMPs into mast cells and for maintaining gene expression in mast cells in vitro. 26 However, the in vivo roles of GATA2 in mast cell differentiation and maintenance have not been investigated. To address this, we generated CTMC-specific Gata2-deficient mice by crossing Gata2 f/f mice to CTMCspecific Mcpt5-Cre mice. 34 Gata2 f/f Mcpt5-Cre mice exhibited a nearly complete deficiency of mast cells in the ear skin, stomach, trachea and peritoneal cavity while having comparable numbers of basophils (Fig 1, A and B ) and T cells, B cells, dendritic cells, natural killer cells, neutrophils, and macrophages (see Fig E1) . Thus we refer to
To analyze whether CTMC-deficient mice have compromised mast cell functions, we performed passive cutaneous anaphylaxis (PCA), an assay that measures cutaneous mast cell degranulation, as well as PSA. We found that CTMC-deficient mice did not have PCA and PSA in response to antigen and antigen-specific IgE cross-linking of FcεRI (Fig 1, C and D) . These mice did not release histamine 5 minutes after antigen challenge (5% of controls; Fig 1, E) . Mouse mast cell protease 1 (MMCP-1) is a protease predominantly expressed by mucosal mast cells. 35 To determine whether CTMC-deficient mice retain the ability to produce MMCP-1, we examined MMCP-1 levels in the serum of the sensitized and challenged mice and found that CTMCdeficient mice produced 47% less MMCP-1 than wild-type controls (Fig 1, F) , suggesting that approximately half of the mucosal mast cells in Gata2 f/f Mcpt5-Cre mice are also impaired by the absence of the Gata2 gene. These data demonstrate that GATA2 is critical for CTMC differentiation and function in vivo and suggest that GATA2 also contributes to the differentiation and function of mucosal mast cells that express MMCP-1.
To distinguish the role of GATA2 in maintaining expression of genes required for mediating anaphylaxis from its role in CTMC differentiation, we acutely deleted the Gata2 gene in differentiated BMMCs and tested whether Gata2 2/2 BMMCs restore the ability of CTMC-deficient mice to have anaphylactic reactions. To prepare Gata2 2/2 BMMCs, we treated BMMCs cultured from conditional Gata2 knockout (Gata2
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Yfp/Yfp TgCreErt2 hemi mice) or littermate control mice (Gata2
Yfp/Yfp TgCreErt2 hemi mice) with 4-hydroxytamoxifen for 11 days to delete the Gata2 gene, as described previously. 26 Yellow fluorescent protein (YFP) 1/1 BMMCs completely restored the ability of CTMC-deficient mice to experience anaphylaxis (Fig 1, G) . Our data establish that GATA2 is essential in maintaining the expression of genes required for anaphylaxis.
The transcription factor MITF, but not aryl hydrocarbon receptor, aryl hydrocarbon receptor repressor, or basic helix-loop-helix family member E40, regulates Hdc gene expression and IgE/mast cell-mediated anaphylaxis Our previous study showed that GATA2 is critical for Hdc gene expression in mast cells. 26 However, it remained unclear whether GATA2 directly regulates the Hdc gene or regulates it indirectly by inducing the expression of Hdc gene-regulating transcription factors. Mast cells express higher levels of Hdc transcripts. 36 Therefore we reasoned that transcription factors that are highly expressed in mast cells, but not in basophils, are more likely to play a role in regulating the Hdc gene. We analyzed our published microarray data that profiled gene expression in mast cells versus basophils 30 and identified 15 transcription factor genes that are expressed to a much greater extent in mast cells than in basophils. These include Mitf, aryl hydrocarbon receptor repressor (Ahrr), aryl hydrocarbon receptor (Ahr), hypermethylated in cancer 1 (Hic1), MDS1 and EVI1 complex locus (Mecom), basic helix-loop-helix family member E40 (Bhlhe40), basic leucine zipper ATF-like transcription factor 1 (Batf1), EP300 interacting inhibitor of differentiation 2 (Eid2), inhibitor of DNA binding 2 (Id2), MyoD family inhibitor domain containing (Mdfic), Meis homeobox 1 (Meis1), myeloid zinc finger 1 (Mzf1), progesterone receptor (Pgr), T cell acute lymphocytic leukemia 1 (Tal1), and Zinc Finger Homeobox 3 (Zfhx3) (Fig 2, A) . In this study we selected the transcription factor genes Mitf, Ahr, Ahrr, and Bhlhe40 for further study because MITF has been shown to play a critical role in mast cell differentiation and because mice deficient in Ahr, 37 Ahrr (National Institutes of Health Knockout Mice Project), and Bhlhe40 38 genes are available, which allowed investigation of the role of these genes in mast cell differentiation by using both gene deletion and gene suppression (short hairpin RNA [shRNA]) approaches. Using qPCR, we verified that Mitf, Ahr, Ahrr, and Bhlhe40 mRNA were expressed to a much greater extent in mast cells than in basophils (fold difference [mast cells/basophils]: Mitf, 8.8; Ahr, 33.2; Ahrr, 17.2; and Bhlhe40, 19.8; Fig 2,  B) . Furthermore, expression of these transcription factor genes in mast cells is dependent on GATA2 (percentages of reduction in Gata2 2/2 BMMCs: Ahr, 79.9%; Ahrr, 94.5%; Bhlhe40, 86.8%; and Mitf, 60.8%; Fig 2, C) .
Mitf null mutant mice on a C57Bl/6 background do not have mature mast cells. 39, 40 To determine whether the GATA2-dependent transcription factors MITF, AHR, AHRR, and BHLHE40 regulate the Hdc gene, we used an shRNA knockdown approach. We examined Hdc mRNA expression in BMMCs with mice). C, PCA analysis (mean 6 SEM, n 5 3 mice). D, PSA analysis (mean 6 SEM, n 5 6 mice). E, ELISA analysis of histamine (mean 6 SEM, n 5 3 samples from 3 individual mice). F, ELISA analysis of MMCP-1 (mean 6 SEM, n 5 3 samples from 3 individual mice). G, PSA analysis of Gata2
Mcpt5-Cre mouse-reconstituted BMMCs (mean 6 SEM, n 5 5 mice). Statistical differences were analyzed by using the Student t test (Fig 1, A-C , E, and F) or ANOVA (Fig 1, D and G) . *P < .05, **P < .01, and ***P < .001. = J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 4 knocked down Mitf (short hairpin Mitf), Ahr (short hairpin Ahr), Ahrr (short hairpin Ahrr), or Bhlhe40 (short hairpin Bhlhe40) mRNA expression. We found that Hdc mRNA expression was significantly diminished (70% reduction) in BMMCs with knocked down Mitf mRNA expression (Fig 3, A) but not in BMMCs with knocked down Ahr, Ahrr, or Bhlhe40 mRNA (Fig  3, B) . BMMCs with knocked down Mitf mRNA expression also synthesized less histamine (68% reduction ; Fig 3, A) . BMMCs with knocked down Mitf mRNA expression but not with control shRNA targeting random sequences or with knocked down Ahr, Ahrr, or Bhlhe40 mRNA expression did not restore anaphylaxis in CTMC mice (Fig 3, C) .
BMMCs are considered to be immature because they contain low levels of histamine. 41, 42 To determine whether MITF is also required for Hdc mRNA expression and histamine synthesis in mature mast cells, we knocked down Mitf mRNA expression in mature peritoneal cavity mast cells (PCMCs) and found that PCMCs with knocked down Mitf mRNA expressed 65% less Hdc mRNA and synthesized 75% less histamine than normal control mast cells (Fig 3, D) . Knockdown of Mitf mRNA expression . Right, ELISA analysis of the histamine contents in BMMCs with knocked down Mitf mRNA (shMitf) or with shRNA control (mean 6 SEM, n 5 3 samples from 3 individual mice). B, qPCR analysis of Hdc mRNA expression in BMMCs with knocked down Ahr mRNA (shAhr), Ahrr mRNA (shAhrr), and Bhlhe40 mRNA (shBhlhe40) or with shRNA control (shCTRL; mean 6 SEM, n 5 3 samples from 3 individual mice). ns, Not significant. C, PSA analysis of Gata2 f/f Mcpt5-Cre mice reconstituted with BMMCs with knocked down Mitf mRNA (n 5 4 mice), Ahr mRNA (n 5 3 mice), Ahrr mRNA (n 5 3 mice), Bhlhe40 mRNA (n 5 3 mice), or shRNA control (n 5 4 mice). Statistical differences in PSA analysis were analyzed by using ANOVA. *P < .05 and **P < .01. D, qPCR analysis of Hdc gene expression (left panel) and ELISA analysis of histamine content (right panel) in PCMCs with knocked down Mitf mRNA (shMitf) or with shRNA control (shCTRL; mean 6 SEM, n 5 3 samples from 3 individual mice). E, qPCR analysis of HDC gene expression (left panel) and ELISA analysis of the histamine contents (right panel) in the human mast cell line LAD2 with knocked down Mitf mRNA (shMitf) or with shRNA control (shCTRL; mean 6 SEM, n 5 3 transduced samples).
did not lead to mast cell death or downregulation of Fcer1a mRNA expression (see Fig E5) .
To verify the results obtained by using the shRNA knockdown approach, we examined the Hdc mRNA in mature PCMCs of Ahr , or Bhlhe40 2/2 mice and littermate control mice (see Fig E6) . In agreement with these findings, Ahr 2/2 (see Fig E7, A) , Ahrr 2/2 (see Fig E8, A) , and Bhlhe40 2/2 (see Fig E9, A) mice had normal numbers of mast cells in the ear skin, stomach, trachea and peritoneal cavity. These mice also had normal PCA (see Fig E7, B; Fig E8, B; and Fig E9, B) and PSA (see Fig E7, C; Fig E8, C; and Fig E9, C) results.
A recent study comparing mouse and human mast cell gene signatures found considerable similarity in gene expression between mast cells from these 2 species. 43 This observation prompted us to investigate whether MITF regulates the Hdc gene in human mast cells. We knocked down human MITF mRNA expression in LAD2 human mast cells, which have high levels of HDC mRNA and histamine. 44 LAD2 cells with knocked down Mitf mRNA expressed 69% less HDC mRNA and synthesized 62% less histamine than negative control LAD2 cells (Fig 3, E) . Collectively, these results demonstrate that MITF, but not any of the other GATA2-dependent transcription factors, regulates Hdc gene expression and histamine synthesis in both mouse and human mast cells, as well as IgE/mast cell-mediated anaphylaxis in mice.
Identification of putative Hdc enhancers
Although our experiments established roles for MITF in regulating the Hdc gene and anaphylaxis, they did not provide evidence that MITF directly regulates the Hdc gene. To address this, we studied MITF binding of Hdc enhancers. Epigenomic studies demonstrate that monomethylation of lysine 4 on histone 3 (H3K4me1) marks genes that are poised to be transcribed, whereas acetylation of lysine 27 on histone 3 (H3K27ac) identifies genes that are being transcribed actively. The combined presence of H3K4me1 and H3K27ac modifications predicts enhancer activity. [45] [46] [47] [48] [49] To detect these marks genome wide, we performed H3K4me1 and H3K27ac ChIP-seq analysis of BMMCs. We used BMMCs because they recapitulate Hdc gene expression in peritoneal mast cells analyzed directly ex vivo. We found 2 putative Hdc enhancers (defined by both H3K4me1 and H3K27ac histone modifications) located 28.8 kb upstream and 10.3 kb downstream from the transcription start site of the Hdc gene (indicated in Fig 4, A, by red lines) . We also note that there are 2 H3K4me1 peaks located around the 18.5 kb region. However, H3K27ac peaks in the locations were insignificant based on our peak calling statistical analysis (Fig 4, A) . Thus we did not consider these 2 H3K4me1 peaks further as putative Hdc enhancers.
To determine whether the putative Hdc enhancers function in Hdc gene transcription, we constructed a luciferase reporter gene in which luciferase expression is under the control of the Hdc minimal promoter (244 to 11 relative to the transcription start site) and the 28.8 or 10.3 Hdc enhancer (a schematic diagram is shown in Fig 4, B, upper panel) . We found that the 28.8 Hdc enhancer dramatically increased the activity of the Hdc minimal promoter (13.4-fold increase; Fig 4, B, lower panel) , whereas the 10.3 Hdc enhancer did not show significant enhancer activity.
MITF binds to the 28.8 Hdc enhancer and drives its activity
To determine whether MITF binds to the 28.8 Hdc enhancer, we aligned our H3K4me1 and H3K27ac ChIP-seq data from this region with the published MITF ChIP-seq data 50 and found 1 statistically significant MITF-binding peak in the 28.8 Hdc enhancer (Fig 5, A) . Our ChIP-qPCR analysis of MITF binding in BMMCs revealed that among 5 predicted MITF-binding sites located within the 28.8 and 10.3 Hdc enhancers (Fig 5, A) , MITF binding was only detected at 2 MITF-binding sites located in the 28.8 Hdc enhancer (eg, MITF-binding sites 3 and 4, a 6.3-fold enrichment found in the combined binding sites; Fig 5, B) .
BMMCs and the CFTL-15 mast cells we used to analyze Hdc enhancer activity are considered immature mast cells because they contain low amounts of histamine and express fewer receptors for IgE than mature mast cells. [51] [52] [53] To determine whether binding of MITF to the 28.8 Hdc enhancer increases in mature mast cells, we measured MITF binding both in BMMCs that were induced to mature and in mature PCMCs. BMMCs were induced to mature by cholera toxin treatment, as previously reported. 54 We found that Hdc mRNA expression levels and histamine content were enhanced 8.9-and 4.7-fold, respectively, by cholera toxin treatment (Fig 5, C and D) . Concomitantly, the binding of MITF to the 28.8 Hdc enhancer also increased to levels similar to those of mature PCMCs (fold enrichment [anti-MITF antibody/IgG]: untreated BMMCs, 7.4; cholera toxin-treated BMMCs, 11.2; and PCMCs, 11.7; Fig 5, E) .
To determine whether MITF activates 28.8 Hdc enhancer activity, we prepared CFTL-15 mast cells with control or knocked down Mitf mRNA, followed by transfection of the 28.8 Hdc enhancer luciferase reporter gene construct. The 28.8 Hdc enhancer lost approximately 60% of its activity in the presence of knocked down (by 80%) Mitf mRNA (Fig 6, A) . Conversely, overexpression of MITF in a non-mast cell line greatly increased the activity of the 28.8 Hdc enhancer (8.2-fold increase; Fig 6,  B) . Mutations in MITF-binding sites 3 and 4, but not MITFbinding site 5, abolished the MITF/28.8 Hdc enhancer-driven FIG 5 . MITF binds to the 28.8 enhancer in immature and mature mast cells. A, Enlarged ChIP-seq peak plots of the Hdc E-8.8 region and Hdc E10.3 region. Published MITF ChIP-seq data were aligned with our H3K4me1 and H3K27ac ChIP data by using the Integrative Genomics Viewer. The black bar beneath the MITF ChIP-seq peak plot indicates the MITF-binding peak that is statistically significant. Red bars indicate the positions of consensus MITF-binding sites (BSs). B, ChIP-qPCR analysis of MITF binding (mean 6 SEM, n 5 2 samples from 2 independent experiments). BMMCs, anti-MITF antibody, or control IgG were used for immunoprecipitation. ns, Not significant. C, qPCR analysis of the Hdc mRNA expression (mean 6 SEM, n 5 3 samples from 3 individual mice). D, ELISA analysis of histamine content (mean 6 SEM, n 5 3 samples from 3 individual mice). E, ChIP-qPCR analysis of MITF binding in untreated BMMCs, cholera toxin-treated BMMCs, and PCMCs (mean 6 SEM, n 5 3 samples from 3 independent experiments). CT, Cholera toxin. luciferase reporter gene activity (percentages of reduction: BS3 Mut, 98%; BS4 Mut, 92%; and BS345 Mut, 92%; Fig 6, C) 
Gata2
f/f BMMCs were acutely depleted of the Gata2 gene by using 4-hydroxytamoxifen treatment for 11 days. 26 Our results confirmed that overexpression of MITF is sufficient to drive expression of the Kit and Fcer1a genes (Fig 7, A) but only partially restored Hdc gene expression approximately 63% relative to the wild-type control (Fig 7, B) . In contrast, overexpression of GATA2 completely restored Hdc gene expression (146% of wild-type; Fig 7, B) . Together, these results indicate that GATA2 regulates Hdc expression though inducing MITF and that additional GATA2-dependent mechanisms are required for full expression of the Hdc gene in mast cells.
DISCUSSION
Our results demonstrate that a GATA2-MITF regulatory circuit controls IgE/mast cell-mediated anaphylaxis in mast cells. Previous studies established that GATA2 plays a crucial role in mast cell development. We and others have demonstrated that GATA2 is essential for differentiation of pre-BMPs into mast cells and is required for maintaining the molecular program that defines mast cells in vitro. 26, 55 In this study we present evidence that GATA2 is required for differentiation of CTMCs in vivo. Although CTMCdeficient mice did not release histamine in response to antigen and antigen-specific IgE cross-linking of FcεRI, these mice retained the capacity to secrete MMCP-1, although in reduced amounts. Our findings are consistent with evidence that CTMCs play a major role in inducing anaphylaxis. 56 Taking advantage of CTMCdeficient mice in adoptive transfer experiments, we demonstrated that GATA2 was essential for maintaining the ability of mast cells to mediate anaphylaxis in response to antigen and antigenspecific IgE cross-linking of FcεRI.
Our study sheds light on molecular mechanisms by which transcription factors regulate IgE/mast cell-mediated anaphylaxis. We and others confirmed previously that GATA2 is the major transcription factor required for maintaining the expression of many, if not all, mast cell signature genes. 26, 55 These results indicated that GATA2 initiates a regulatory hierarchy composed of many transcription factors that synergistically control expression of mast cell-specific genes. Here we show that GATA2 induces expression of the transcription factor-encoding Mitf, Ahr, Ahrr, and Bhlhe40 genes. We also found that expression of Ahr, Ahrr, and Bhlhe40 depends on MITF (Li et al, unpublished data), indicating that MITF functions at a higher level within the hierarchy than AHR, AHRR, and BHLHE40. Consistent with this model, MITF is critically involved in regulating the expression of Hdc, as well as additional genes in mast cells (Li et al, unpublished data Furthermore, we demonstrated that Mitf gene expression is required to maintain Hdc gene expression in mature mast cells. In contrast to the 28.8 enhancer, the 10.3 downstream Hdc enhancer lacks detectable enhancer activity. However, the in vivo importance of this enhancer in Hdc gene transcription cannot be ruled out by the luciferase reporter gene transcription assay alone.
Although mouse and human mast cells share expression of similar gene programs, direct evidence that MITF plays a critical role in regulating Hdc gene expression and histamine synthesis in human mast cells lays a solid foundation for future studies of how the human HDC gene is transcriptionally regulated. This will enable a more comprehensive understanding of how histamine synthesis and release are controlled.
Although MITF fully restored c-Kit and FcεRIa expression, it only restored Hdc gene transcription to an average of 63% of wild-type amounts. This suggests that in addition to inducing MITF expression, GATA2 is directly involved in regulating the Hdc gene. Feed-forward loop transcription circuits regulate gene expression in many developmental systems. 59 This regulation involves three classes of factors. First, a primary transcription factor gene (gene product) regulates the expression of a second transcription factor gene. The primary and secondary transcription factors bind the regulatory region of a third (target) gene and cooperatively regulate its transcription. 59 Our data support that GATA2, MITF, and the Hdc gene form a feed-forward loop. In this mode of action, it is possible that in addition to inducing MITF expression, GATA2 maintains the accessibility of the Hdc promoter and/or enhancers and that GATA2 can function by coordinating interactions between promoter and enhancers modules. It is also possible that GATA2 cooperates with MITF to optimally transcribe the Hdc gene. Thus our findings that GATA2 and MITF regulate IgE/mast cell-mediated anaphylaxis mainly by regulating the Hdc enhancer add new knowledge how enhancers and their associated transcription factors regulate anaphylaxis.
Genes are typically regulated by a set of transcription factors that bind together to clustered binding sites within an enhancer region. 49, 60, 61 One of the best-studied examples is the human IFNB enhancer, which is activated by multiple transcription factors in response to intracellular signaling pathways. 62 Our findings confirm a central role for MITF in coordinating a cluster of transcription factor-binding sites within the Hdc enhancer to regulate histamine synthesis. Future studies will address how Hdc enhancers interact with the Hdc promoter, as well as how other transcription factors cooperatively regulate the Hdc gene.
